SCHEMBL20710022

SCHEMBL20710022

C=C1N(C(C)CC)CCN1C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24335867 0.78 PKM (0.30) —
SCHEMBL21946652 0.65 — —
SCHEMBL8242236 0.63 — —
SCHEMBL10001843 0.63 LMNA (0.37) —
SCHEMBL16252942 0.63 LMNA (0.37) —
SCHEMBL10074140 0.60 LMNA (0.32) —
SCHEMBL21325293 0.60 — —
SCHEMBL12528611 0.60 PIK3CD (0.33) —
SCHEMBL4227055 0.60 — —
SCHEMBL24847400 0.60 PER2 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11028078-B2 Itraconazole analogs and use thereof THE JOHNS HOPKINS UNIVERSITY (US) 2021-06-08 — — US disclosed
US-20190040046-A1 ITRACONAZOLE ANALOGS AND USE THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2019-02-07 — — US disclosed
Send feedback